UNASSIGNED: We conducted a systematic review to explore the ocular manifestations of COVID-19. We searched online databases including PubMed, Embase, Scopus, and Web of Science up to September 4, 2023. After a two-stage screening process and applying inclusion/exclusion criteria, eligible articles were advanced to the data extraction phase. The PRISMA checklist and Newcastle-Ottawa Scale (NOS) were used for quality and bias risk assessments.
UNASSIGNED: We selected and extracted data from 42 articles. Most of the studies were cross-sectional (n = 33), with the highest number conducted in Turkey (n = 10). The most frequent ocular manifestation was conjunctivitis, reported in 24 articles, followed by photophobia, burning, chemosis, itching, and ocular pain. Most studies reported complete recovery from these manifestations; however, one study mentioned visual loss in two patients.
UNASSIGNED: In general, ocular manifestations of COVID-19 appear to resolve either spontaneously or with supportive treatments. For more severe cases, both medical treatment and surgery have been employed, with the outcomes suggesting that complete recoveries are attainable.
■我们进行了系统评价,以探讨COVID-19的眼部表现。我们搜索了包括PubMed在内的在线数据库,Embase,Scopus,和WebofScience至2023年9月4日。经过两个阶段的筛选过程并应用纳入/排除标准,符合条件的文章被推进到数据提取阶段.PRISMA检查表和纽卡斯尔-渥太华量表(NOS)用于质量和偏倚风险评估。
■我们从42篇文章中选择并提取了数据。大多数研究都是横断面的(n=33),在土耳其进行的次数最多(n=10)。最常见的眼部表现是结膜炎,在24篇文章中报道,其次是畏光,燃烧,化疗,瘙痒,和眼部疼痛。大多数研究报告从这些表现中完全恢复;然而,一项研究提到两名患者的视力丧失。
■一般来说,COVID-19的眼部表现似乎可以自发或通过支持治疗解决。对于更严重的病例,医疗和手术都被采用了,结果表明,完全复苏是可以实现的。